细胞凋亡与甲状腺疾病
摘要
细胞凋亡是由基因控制的自主性有序死亡,经特定的程序出现细胞皱缩、染色质浓缩和凋亡小体。细胞凋亡受抑制,会导致自身免疫性疾病或肿瘤,而不恰当的激活则会发生组织器官的退行性病变。
出处
《中外医疗》
2008年第13期72-72,共1页
China & Foreign Medical Treatment
参考文献9
-
1段薇,黄华,杜建玲,李昌臣,关宏伟,韩辉.自身免疫性甲状腺疾病甲状腺组织中bcl-2家族蛋白的表达[J].中国地方病学杂志,2005,24(3):271-274. 被引量:4
-
2史治宙,姬秋和,王瑞华,殷玉华,赵霞,高彬.T_3对人外周血淋巴细胞肿瘤坏死因子相关凋亡诱导配体表达及细胞凋亡的影响[J].中华内分泌代谢杂志,2005,21(5):457-459. 被引量:4
-
3[3]Chen BK,Ohtsuki Y,Furihata M,et al.Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary treatment carcinomas correlated with lymph node metastasis,tumor size and clinicopathologic stage[J].Int J Oncol,1995,15(5):893~898.
-
4[4]Pilotti S,Collini P,Rike F,et al.Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland[J].J Pathol,1994,172(4):337~342.
-
5[5]Hinze R,Gimm O,Taubert H,et al.Regulation of proliferation and apoptosis in sporadic and hereditary medullary thyroid carcinomas and their putative precursor lesions[J].Virchows Arch,2000,437(3):256~263.
-
6[6]Massart C,Barbet R,Genetet N,et al.Doxorubicin induces Fas-mediated apoptosis in human thyroid carcinoma cells[J].Thyroid,2004,14(4):263~270.
-
7[7]Nagayama Y,Yokoi H,Takeda K.Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo[J]:J Clin Endocrinol Metab,2000,85(11):1081~1086.
-
8[8]Liu Z,Falola J,Zhu X,et al.Antiprolfferative effects of Src inhibition on meduuary thyroid cancerp[J].J Clin Endocrinol Metab,2004,89(7):3503~3509.
-
9夏燕萍,俞茂华.茶多酚抑制人甲状腺乳头状癌细胞生长[J].中华内分泌代谢杂志,2005,21(4):366-368. 被引量:6
二级参考文献35
-
1Eguchi K. Apoptosis in autoimmune disease[J]. Intern Med, 2001,40 (4): 275-284.
-
2Giordano C,Richiusa P, Baguasco M ,et al. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease [J ]. Thyroid, 2001, 11 (3): 233-244.
-
3Bouillet P,Andreas S. BH3-only proteins-evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death[J]. J Cell Sci, 2002, 11S(Pt8 ): 1567-1574.
-
4Belinda C,Baliga,Kumar S. Role of Bcl-2 family in maligancy[J].Hematol Oncol, 2002,20 (2): 63-74.
-
5Shangary S, Johnson DE. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2,Bcl-x(L) and Bax oligomerization, induction of cytochrome c release,and activation of cell death[J]. Biochemistry, 2002, 41 ( 30 ): 9485-9495.
-
6Johnson AL. Editorial: Mcl-1-just another antiapoptotic Bcl-2 homolog[J]? Endocrinology, 1999,140(12) :5465-5468.
-
7Mitsiades N,Poulaki V,Kotoula V,et al. Fas/Fas ligand up-regulation and Bcl-2 down regulation maybe significant in the pathogenesis of Hashimoto's thyroiditis [J]. J Clin Endocrinol Metab, 1998,83 (6): 2199-2203.
-
8Judelson C, Privalsky ML. DNA recognition by normal and oncogenic thyroid hormone receptors. Unexpected diversity in half-site specificity controlled by non-zinc-finger determinants. J Biol Chem, 1996,271:10800-10805.
-
9Gandrillon O, Ferrand N, Michaille JJ, et al. c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene. Oncogene, 1994,9:749-758.
-
10Brown DD, Wang Z, Kanamori A, et al. Amphibian metamorphosis: a complex program of gene expression changes controlled by the thyroid hormone. Recent Prog Horm Res,1995,50:309-315.
共引文献11
-
1张艳秋,孟凡玲.茶多酚的生物学效应及其在运动中的应用机制[J].山西师大体育学院学报,2006,21(z1):138-140. 被引量:14
-
2汪华君,戴淑芳,王丽,田晓光,李淑媛.茶多酚对麻醉大鼠血流动力学的影响[J].大连医科大学学报,2006,28(2):104-108. 被引量:1
-
3苏文土,郭爱萍.茶多酚防癌抗癌研究进展[J].福建茶叶,2007,30(1):7-10. 被引量:4
-
4金秀平,李明,赵杰,马绍杰,贾伟,陈冬,吴乃君,张秀军.PDCD5基因在初诊Graves'病患者PBMCs中表达情况的初步研究[J].西安交通大学学报(医学版),2007,28(3):241-243. 被引量:5
-
5易海维,李彦荣,孟依,衣卫杰,刘烈刚,孙秀发,应晨江.红茶多酚对主动脉内皮细胞增殖抑制作用[J].中国公共卫生,2007,23(10):1187-1188. 被引量:5
-
6武革,吴雪梅,曹军,吴冬梅.自身免疫性甲状腺疾病甲状腺组织中凋亡调控蛋白Fas/FasL、Bcl-2/Bax的表达及意义[J].临床内科杂志,2007,24(11):763-765. 被引量:9
-
7赵杰,陈晶,赵丽娜,张秀军.程序性死亡因子5在Graves病和桥本甲状腺炎中表达的初步研究[J].中国煤炭工业医学杂志,2009,12(1):4-6. 被引量:2
-
8魏军平,刘恒亮,张璨.中医药促进甲亢细胞凋亡的研究进展[J].世界中西医结合杂志,2011,6(12):1085-1088. 被引量:2
-
9唐诗,辛颖.儿童桥本甲状腺炎的研究进展[J].中国中西医结合儿科学,2013,5(6):488-491. 被引量:4
-
10刘芳.茶多酚在运动中的生物活性作用原理探究[J].福建茶叶,2016,38(3):31-32. 被引量:3
-
1余月.基因与遗传病[J].走近科学,2003(2):20-22.
-
2美科学家研究炭疽病获得进展[J].国际医药卫生导报,2001,7(11B):31-31.
-
3刘洋,朱莹莹,史莹,姜瑛.原发性甲状旁腺功能亢进症的诊治[J].中国实验诊断学,2015,19(2):230-232. 被引量:2
-
4张平.细胞受到感染病毒后会自杀的土豆[J].世界发明,1997(4):16-16.
-
5甲状腺疾病[J].国外科技资料目录(医药卫生),1997(3):81-82.
-
6杜昕(译).工作压力过大对心脏有害[J].英国医学杂志中文版,2008,11(1):32-32.
-
7赵华,张建军.脂蛋白(a)在心血管疾病中的作用[J].中国临床医生杂志,2016,44(11):6-10. 被引量:15
-
8马文林,戚秀卿,邓南伟,顾惠琴.血管紧张素转化酶抑制剂对心力衰竭患者自主神经昼夜节律的影响[J].临床心血管病杂志,2006,22(1):33-35. 被引量:6
-
9陈宝珍.血管紧张素转换酶抑制剂对心力衰竭患者心率变异性的影响[J].现代中西医结合杂志,2007,16(36):5453-5454. 被引量:2
-
10罗泽中.中西结合治疗糖尿病自主性神经病变的临床探索[J].四川中医,2004,22(11):37-38.